Locus coeruleus and norepinephrine in Parkinson's disease.
Chan-Palay
V
V
Neurology Clinic, University Hospital, Zurich, Switzerland.
D000368:Aged; D000369:Aged, 80 and over; D001931:Brain Mapping; D003198:Computer Simulation; D005260:Female; D019004:Galanin; D006801:Humans; D008125:Locus Coeruleus / Q000503:physiopathology*; D008297:Male; D008959:Models, Neurological; D009410:Nerve Degeneration / Q000502:physiology; D009474:Neurons / Q000502:physiology; D009478:Neuropeptide Y / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology*; D010446:Peptide Fragments / Q000502:physiology; D010455:Peptides / Q000502:physiology
D009478:Neuropeptide Y; D010446:Peptide Fragments; D010455:Peptides; C048612:neuropeptide Y C-terminal flanking peptide; D019004:Galanin; D009638:Norepinephrine